Insider trading

Period: 120 months Stock: OLMA Minimum amount: $100K × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

74 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

74 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

74 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

74 decisions over 120 months Remove this filter
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
74 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
74 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

74 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
24 Jul 2026
Harmon Cyrus Director
Sold at will
$146.43K 12,500 at 11.71
1.7%
Not planned
23 Jul 2026
Harmon Cyrus Director
Sold at will
$144.74K 12,500 at 11.58
1.7%
Not planned
4 Mar 2026
Mitchell Shawnte CHIEF LEGAL OFFICER
Sold at will 2×
$606.35K 25,000 at 24.25
100%
Sold half or more
3 Mar 2026
Mitchell Shawnte CHIEF LEGAL OFFICER
Sold at will
$345.15K 15,000 at 23.01
100%
Sold half or more
20 Jan 2026
Harmon Cyrus Director
Sold at will
$268.80K 10,000 at 26.88
1.4%
Not planned
15 Jan 2026
Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF.
Sold at will
$2.87M 100,000 at 28.73
41.7%
Not planned
14 Jan 2026
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF
Sold at will 2×
$1.44M 50,000 at 28.87
8.4%
Not planned
14 Jan 2026
Harmon Cyrus Director
Sold at will
$101.60K 3,489 at 29.12
0.5%
Not planned
13 Jan 2026
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF
Sold at will 2×
$1.38M 50,000 at 27.60
8.4%
Not planned
13 Jan 2026
Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF.
Sold at will
$107.05K 3,822 at 28.01
1.6%
Not planned
12 Jan 2026
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF · indirect
Sold at will
$283.40K 10,000 at 28.34
6.5%
Not planned
23 Dec 2025
Zojwalla Naseem Chief Medical Officer
Sold at will
$2.75M 99,509 at 27.66
95.7%
Sold half or more
22 Dec 2025
Zojwalla Naseem Chief Medical Officer
Sold at will
$2.80M 100,000 at 28.04
64.9%
Sold half or more
19 Dec 2025
CLARK IAN T Director
Sold at will 3×
$7.87M 264,800 at 29.73
100%
Sold half or more
19 Dec 2025
Zojwalla Naseem Chief Medical Officer
Sold at will 2×
$1.97M 70,000 at 28.20
40.2%
Not planned
19 Dec 2025
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF
Sold at will 3×
$1.55M 51,000 at 30.46
8.5%
Not planned
8 Jan 2025
Bought
$1.73M 300,000 at 5.76
4.0%
First buy on file
17 Dec 2024
Graham G. Walmsley Director · indirect
Sold at will
$4.73M 700,761 at 6.75
100%
Sold half or more
17 Dec 2024
Graham G. Walmsley Director · indirect
Sold at will
$4.73M 700,761 at 6.75
33.2%
Not planned
11 Dec 2024
Bohen Sean PRESIDENT AND CEO
Sold at will 2×
$496.05K 57,174 at 8.68
19.1%
Not planned
11 Dec 2024
Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF.
Sold at will 2×
$159.26K 18,356 at 8.68
3.3%
Not planned
11 Dec 2024
Zojwalla Naseem CHIEF MEDICAL OFFICER
Sold at will 2×
$125.99K 14,522 at 8.68
11.2%
Not planned
11 Dec 2024
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF
Sold at will 2×
$118.12K 13,614 at 8.68
2.2%
Not planned
10 Dec 2024
Bohen Sean PRESIDENT AND CEO
Sold at will
$490.31K 52,328 at 9.37
14.9%
Not planned
10 Dec 2024
Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF.
Sold at will
$157.44K 16,803 at 9.37
2.9%
Not planned
10 Dec 2024
Zojwalla Naseem CHIEF MEDICAL OFFICER
Sold at will
$124.46K 13,283 at 9.37
9.3%
Not planned
10 Dec 2024
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF
Sold at will
$116.80K 12,452 at 9.38
2.0%
Not planned
1 Aug 2024
Paradigm Biocapital Advisors LP 10% owner · indirect
Sold at will 2×
$35.80M 2,400,000 at 14.92
75.4%
Sold half or more
28 Jun 2024
Harmon Cyrus Director
Sold on a plan
$215.40K 20,000 at 10.77
2.6%
Planned (10b5-1)
4 Jun 2024
Graham G. Walmsley Director · indirect
Sold at will 2×
$17.45M 1,175,000 at 14.85
62.6%
Sold half or more
31 May 2024
Harmon Cyrus Director
Sold on a plan
$141.15K 15,000 at 9.41
1.9%
Planned (10b5-1)
30 Apr 2024
Harmon Cyrus Director
Sold on a plan
$142.65K 15,000 at 9.51
1.8%
Planned (10b5-1)
28 Mar 2024
Harmon Cyrus Director
Sold on a plan
$219.40K 20,000 at 10.97
2.4%
Planned (10b5-1)
29 Feb 2024
Harmon Cyrus Director
Sold on a plan 2×
$310.31K 25,000 at 12.41
2.9%
Planned (10b5-1)
31 Jan 2024
Harmon Cyrus Director
Sold on a plan
$305.75K 25,000 at 12.23
2.8%
Planned (10b5-1)
29 Dec 2023
Harmon Cyrus Director
Sold at will 2×
$334.50K 25,000 at 13.38
2.7%
Not planned
6 Dec 2023
Paradigm Biocapital Advisors LP 10% owner · indirect
Bought
$1.16M 100,000 at 11.60
1.5%
First buy on file
5 Dec 2023
Graham G. Walmsley Director · indirect
Bought 3×
$1.87M 131,870 at 14.19
7.9%
30 Nov 2023
Harmon Cyrus Director
Sold on a plan
$314.25K 25,000 at 12.57
2.6%
Planned (10b5-1)
22 Nov 2023
Bohen Sean PRESIDENT AND CEO
Sold at will
$388.25K 27,932 at 13.90
16.2%
Not planned
22 Nov 2023
Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF.
Sold at will
$127.02K 9,145 at 13.89
2.1%
Not planned
21 Nov 2023
Bohen Sean PRESIDENT AND CEO
Sold at will 2×
$435.88K 29,293 at 14.88
14.5%
Not planned
21 Nov 2023
Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF.
Sold at will 2×
$142.63K 9,597 at 14.86
2.2%
Not planned
21 Nov 2023
Zojwalla Naseem CHIEF MEDICAL OFFICER
Sold at will 2×
$110.75K 7,461 at 14.84
16.5%
Not planned
21 Nov 2023
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF
Sold at will 2×
$103.82K 6,976 at 14.88
1.2%
Not planned
1 Nov 2023
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF
Sold on a plan
$100.15K 6,668 at 15.02
1.2%
Planned (10b5-1)
31 Oct 2023
Harmon Cyrus Director
Sold on a plan
$301.25K 25,000 at 12.05
2.6%
Planned (10b5-1)
29 Sep 2023
Harmon Cyrus Director
Sold on a plan
$310.25K 25,000 at 12.41
2.5%
Planned (10b5-1)
19 Sep 2023
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF
Sold on a plan
$253.40K 20,000 at 12.67
3.4%
Planned (10b5-1)
12 Sep 2023
Bought 3×
$14.82M 1,505,932 at 9.84
47.3%
+47% of stake
Showing 1–50 of 74. Page 1 of 2 Older →